Search Results - "Jones, A.M"

A community change in the algal endosymbionts of a scleractinian coral following a natural bleaching event: field evidence of acclimatization by Jones, A.M, Berkelmans, R, van Oppen, M.J.H, Mieog, J.C, Sinclair, W

“…type C2, while the remainder harboured a tolerant…”
Get full text

Clostridium difficile : A European perspective by Jones, A.M, Kuijper, E.J, Wilcox, M.H

“…Summary Clostridium difficile infection is the leading cause of diarrhoea in the industrialised world. First identified in 1935, our knowledge about the clonal…”
Get full text

A European aerosol phenomenology – 3: Physical and chemical characteristics of particulate matter from 60 rural, urban, and kerbside sites across Europe by Putaud, J.-P., Van Dingenen, R., Alastuey, A., Bauer, H., Birmili, W., Cyrys, J., Flentje, H., Fuzzi, S., Gehrig, R., Hansson, H.C., Harrison, R.M., Herrmann, H., Hitzenberger, R., Hüglin, C., Jones, A.M., Kasper-Giebl, A., Kiss, G., Kousa, A., Kuhlbusch, T.A.J., Löschau, G., Maenhaut, W., Molnar, A., Moreno, T., Pekkanen, J., Perrino, C., Pitz, M., Puxbaum, H., Querol, X., Rodriguez, S., Salma, I., Schwarz, J., Smolik, J., Schneider, J., Spindler, G., ten Brink, H., Tursic, J., Viana, M., Wiedensohler, A., Raes, F.

“…This paper synthesizes data on aerosol (particulate matter, PM) physical and chemical characteristics, which were obtained over the past decade in aerosol…”
Get full text

136 A retrospective audit of spirometric practice in a large UK adult CF centre against American Thoracic Society and European Respiratory Society guidelines by Waller, I, Johnson, S.C, Jones, A.M

Get full text

WS20.2 High level of β-(1,3)-D-glucan antigenemia in cystic fibrosis in the absence of systemic fungal infection by Rautemaa, V, Green, H, Richardson, R, Jones, A.M

Get full text

IPD1.07 Environmental sampling for fungal species in a UK cystic fibrosis centre by Collier, L.J, Bright-Thomas, R.J, Richardson, M, Jones, A.M

Get full text

248 Exploring the relationship between exercise capacity and pulmonary exacerbations in a UK Adult Cystic Fibrosis Centre by Waller, I, Johnson, S, McVean, R, Webb, A.K, Jones, A.M

Get full text

149 The changing face of airway clearance in the adult cystic fibrosis population by Cathcart, F, Lathia, C, Parrott, H, Jones, A.M, Simmonds, N.J

Get full text

153 The use of the ultrasonic nebuliser for enhanced airway clearance in adults with cystic fibrosis by Cathcart, F, Greenwood, S, Parrott, H, Jones, A.M, Simmonds, N.J

Get full text

ePS02.4 Perceptions of end of life care in adult patients with cystic fibrosis by Cathcart, F, Parrott, H, Ross, J, Jones, A.M, Simmonds, N.J

Get full text

WS14.5 Clinical outcomes of adult cystic fibrosis patients with aspergillus disease in a 5 year period by Collier, L.J, Bright-Thomas, R.J, Baxter, C, Richardson, M, Jones, A.M

Get full text

The clinical significance and impact of interleukin 15 on keratinocyte cell growth and migration by Jones, A.M, Griffiths, J.L, Sanders, A.J, Owen, S, Ruge, F, Harding, K.G, Jiang, W.G

“…Chronic wounds represent a significant burden to health services and are associated with patient morbidity. Novel methods to diagnose and/or treat problematic…”
Get full text

119 The impact of the initiation of aztreonam solution for inhalation (Cayston™) on symptoms, treatment burden and lung function in adults with cystic fibrosis by Riley, D, Johnson, S.C, Bright-Thomas, R.J, Langman, H.B, Jones, A.M

Get full text

ePS02.5 Striving to improve the outpatient journey for adults with cystic fibrosis – a quality improvement project by Talbot, S, Parrott, H, Madge, S, Gyi, K, Jones, A.M, Simmonds, N.J

Get full text

118 Comparison of alternate month versus continuous Cayston™ in adults with cystic fibrosis by Riley, D, Johnson, S.C, Langman, H.B, Bright-Thomas, R.J, Jones, A.M

Get full text

ePS06.8 Fungal disease and triazole treatment in adults with cystic fibrosis, 2012–2014: treatment trends, clinical characteristics and safety by Spurr, L, Bowman, E, Jones, A.M, Schelenz, S, Armstrong-James, D, Simmonds, N.J

Get full text

ePS06.10 Antibiotic desensitisation: a single centre review of 2015 by Dooney, M.K, Cox, K.J, Barry, P.J, Webb, A.K, Jones, A.M, Bright-Thomas, R.J

Get full text

WS08.2 Exploring the potential impact of gastro-oesophageal reflux on CF lung disease by Lord, R.W, Pearson, J.S, Barry, P.J, Whorwell, P.J, Jones, R.B, McNamara, P.S, Beynon, R, Smith, J.A, Jones, A.M

Get full text

293 Reflux, acid suppression therapy and nutritional outcomes in CF by Lord, R.W, Pearson, J.S, Barry, P.J, Whorwell, P.J, Jones, R.B, McNamara, P.S, Beynon, R, Smith, J.A, Jones, A.M

Get full text

165 “Real world” introduction of tobramycin inhalation powder TIP™ in adults with cystic fibrosis by Langman, H.B, Brennan, A.L, Bright-Thomas, R.J, Jones, A.M, Riley, D.W, Johnson, S.C

“…Objectives To evaluate the introduction of TIP in adult patients attending Manchester Adult Cystic Fibrosis Centre. Methods In December 2012 TIP was introduced…”
Get full text